Vialwirebiotech, curated
November 21, 2026, 8:56 AM
October 26, 2026
- 9:38 AM · Pharmaceutical Executive9:38 AM<![CDATA[ Pathos Ai Enters Drug Development Collaboration with Bristol Myers Squibb and Tempus Ai ]]> — Pharmaceutical Executive
- 9:04 AM · SCMP — Tech9:04 AMChinese biotech giant WuXi AppTec raises 2026 outlook after profit surge — SCMP — Tech
- 9:00 AM · BioWorld9:00 AMAscletis files IND for selective amylin receptor agonist ASC-39 — BioWorld
- 8:54 AM · PharmaVoice8:54 AMMS has plenty of drugs. This Ocrevus veteran sees what’s missing. — PharmaVoice
- 7:00 AM · Drug Discovery World7:00 AMNEC presents Phase I/II results for individualised oral neoantigen therapy — Drug Discovery World
- 6:00 AM · Pharmaceutical Technology6:00 AMLunit and Summit to evaluate pathology platform for tumour analysis — Pharmaceutical Technology
October 25, 2026
- 9:30 PM · SCMP — Tech9:30 PMHead of Hong Kong’s new drug regulator pledges to build trust, push innovation — SCMP — Tech
- 6:54 PM · Pharmaceutical Technology6:54 PMESMO26: Bayer’s Phase III Nubeqa win leaves survival and abiraterone questions open — Pharmaceutical Technology
- 6:35 PM · Pharmaceutical Technology6:35 PMESMO26: GSK’s Mo-Rez seeks an edge in a crowded ADC field in ovarian cancer — Pharmaceutical Technology